- by sedlv
- November 30 2020
Nature- biopharma deal makers (November 30, 2020)

mining platform provides access to the finite hitherto hidden drug-like small molecules from the world’s
fresh- and saltwater microbiomes.
Biosortia is building the world’s largest library of microbiome-derived compounds for therapeutic and other applications, by leveraging the company’s microbial harvesting platform to sample and mine aquatic microbiomes at unprecedented scales with sustainable and environmentally friendly approaches. Biosortia is seeking partners interested in accessing compounds and chemistries to develop biologically relevant small molecule leads.